As the 10th anniversary of the Make in India initiative nears, CNBC’s Inside India takes a look at how the nation’s ...

Plus, news about GSK, Novo Nordisk, Tanai Therapeutics, Nomic Bio, Brenus Pharma, Xspray, Achilles Therapeutics, BioXcel Therapeutics and Nuvalent: Ascendis’ $300M offering: The Danish company ...

"GSK reports positive interim data from mRNA influenza vaccine trial" was originally created and published by Clinical Trials ...

British drugmaker GSK on Thursday announced positive results from its mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, saying it would now ...

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...

GSK plc GSK announced that its therapeutic herpes simplex virus (HSV) vaccine candidate, GSK3943104, did not meet the primary ...

GSK assumed full control for the development, manufacturing and commercialization of influenza vaccines through new licensing agreement TÜBINGEN, Germany/BOSTON, USA – September 12, 2024 – CureVac N.V ...

(Alliance News) - GSK PLC on Thursday hailed a "significant advancement" as it reported positive findings from a trial on a possible flu vaccine.

The mRNA seasonal influenza vaccine program would now progress into late-stage clinical development, or Phase 3, GSK said. "Ultimately, our goal is to develop a new best-in-class vaccine to bring ...

With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...

GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a pharmaceutical company has not been extended. GSK has been slowly ...

GLAXOSMITHKLINE (GSK) has confirmed that its manufacturing operations will cease next year as its current contract with a pharmaceutical company has not been extended. GSK has been slowly ...